Comcast Prevails in Part on Striking OpenTV Infringement Contentions

Jun 30, 2017

Reading Time : 2 min

This dispute began in October 2015 when OpenTV approached Comcast about licensing its patent portfolio because it believed certain Comcast products infringed its patents. In October 2016, Comcast filed a declaratory judgment action of non-infringement of ten patents in OpenTV’s portfolio. On March 27, 2017 OpenTV submitted its infringement contentions, which Comcast moved to strike on April 20. In its motion to strike, Comcast contends that OpenTV’s infringement contentions violate Rule 3-1 by: “(1) relying too much on ‘information and belief,’ (2) charting asserted claims for only one or two accused products despite purporting to accuse more products of infringement, (3) asserting indirect infringement theories in generic terms by merely tracking the pertinent statutory language, (4) using only boilerplate language to assert infringement under the doctrine of equivalents, and (5) failing to identify specifically the patent owners’ own ‘instrumentalities and products purportedly embodying [one of the asserted patents].’”

Comcast’s first argument relied on the language of Rule 3-1, which requires an infringement chart to specify where and how each limitation is found in the accused products. The court noted, however, that Rule 3-1 does not prohibit allegations made upon “information and belief.” The Rule distinguishes between identifying elements of the accused product alleged to practice a claim limitation and items of proof showing that the accused elements in fact practice the limitation. The court found that this distinction was appropriate given Comcast’s restriction of its source code and set-top boxes. The court ultimately rejected Comcast’s arguments that OpenTV’s contentions were vague and/or conclusory.

Comcast next argued that OpenTV failed to show that the claims and products charted in its contentions were appropriately representative of all accused products. The court agreed that OpenTV had not shown that all accused products shared the same characteristics as the allegedly representative ones. In fact, OpenTV’s proposed amended contentions called into question whether the originally-charted products were representative because OpenTV refused to limit the universe of accused products based on the characteristics that OpenTV previously alleged were common to all accused products. The court, therefore, did not grant OpenTV leave to amend its contentions to address whether the originally-charted products were representative.

Comcast also argued that OpenTV’s contentions concerning indirect infringement were conclusory and insufficient. OpenTV argued that it incorporated Comcast’s user manuals and screenshots of Comcast’s website to show how Comcast instructed its customers. OpenTV did not, however, expressly tie Comcast’s marketing materials to its allegations of direct infringement. The court found that including boilerplate language without describing what instructions led to what infringing behavior was not enough to disclose indirect infringement under Rule 3-1.

Finally1, Comcast argued OpenTV failed to disclose adequately its theory of infringement under the doctrine of equivalents. The court agreed.

The court granted Comcast’s motion, but did not do so with prejudice. Instead, the court permitted OpenTV to amend its infringement contentions to cure the deficiencies, consistent with the court’s opinion.

Comcast Cable Commc’ns, LLC v. OpenTV, Inc., No. C 16-06180 WHA (N.D. Cal. June 19, 2017).


1 Comcast also argued that OpenTV did not demonstrate that the patent owners’ own ‘instrumentalities and products purportedly embodying [one of the asserted patents].  But OpenTV withdrew this assertion, mooting this point.

Share This Insight

Previous Entries

IP Newsflash

June 6, 2025

In a precedential opinion, the Federal Circuit definitively held that the Patent Trial and Appeal Board has jurisdiction over IPRs that concern expired patents.

...

Read More

IP Newsflash

June 6, 2025

In a patent infringement litigation in the U.S. District Court for the Eastern District of Texas, Judge Rodney Gilstrap denied a joint motion to stay the litigation pending resolution of inter partes review when it was uncertain that all defendants would be bound by the statutory estoppel provision of 35 U.S.C. § 315(e).

...

Read More

IP Newsflash

May 30, 2025

A district court recently dismissed a patent infringement complaint for improper venue under 28 U.S.C. § 1400(b), finding that the storage and distribution of products from an Amazon warehouse was not sufficient to establish that warehouse as a regular and established place of business in the district.

...

Read More

IP Newsflash

May 27, 2025

The Federal Circuit affirmed a District of Delaware finding of non-infringement in an ANDA litigation due to the patentee’s clear and unmistakable disavowal of claim scope during prosecution. Specifically, the court held that statements made during prosecution of a parent application before the asserted claims were allowed amounted to a prosecution disclaimer that extended to subsequent patents in the family. In reaching this conclusion, the court rejected an attempt by the patentee to resurrect the claim scope through a unilateral, self-serving statement made in later applications in the family.

...

Read More

IP Newsflash

May 13, 2025

The Federal Circuit recently affirmed a district court’s holding that patent term extension (PTE) for a reissued patent was properly based on the issue date of the original patent and not that of the reissued patent. The Federal Circuit concluded that, where both the original and reissued patents claimed a drug product under regulatory review, using the issue date of the original patent to calculate PTE comports with both the purpose of the Hatch-Waxman Act and the related statutory context.

...

Read More

IP Newsflash

May 12, 2025

The Patent Trial and Appeal Board recently declined to institute a petition for IPR that was filed on the same day that the petitioner filed another petition challenging the same claims of the same patent. The board was not persuaded by petitioner’s arguments that a second petition was needed due to alleged claim construction issues or the number, length or scope differences of the challenged claims.

...

Read More

IP Newsflash

May 9, 2025

The USPTO Director vacated the board’s decision to institute inter partes review based on an erroneous application of the Fintiv factors. Specifically, the Director found that the board placed too much emphasis on Petitioner’s Sotera stipulation, and not enough emphasis on the investment in the parallel litigation. Weighing the factors as a whole, the Director determined that institution should be denied.

...

Read More

IP Newsflash

May 9, 2025

In an institution decision following the USPTO’s withdrawal of its Fintiv Memo, the board addressed discretionary denial of an IPR under Fintiv in view of a parallel ITC investigation. The board noted it would not consider the now-rescinded June 2022 memo from then-director Vidal which instructed that the PTAB would not deny institution of an IPR or PGR under Fintiv when the request is based on a parallel ITC investigation. The board conducted a Fintiv analysis in view of the ITC investigation, but ultimately determined that discretionary denial was not warranted in this particular situation.

...

Read More

© 2025 Akin Gump Strauss Hauer & Feld LLP. All rights reserved. Attorney advertising. This document is distributed for informational use only; it does not constitute legal advice and should not be used as such. Prior results do not guarantee a similar outcome. Akin is the practicing name of Akin Gump LLP, a New York limited liability partnership authorized and regulated by the Solicitors Regulation Authority under number 267321. A list of the partners is available for inspection at Eighth Floor, Ten Bishops Square, London E1 6EG. For more information about Akin Gump LLP, Akin Gump Strauss Hauer & Feld LLP and other associated entities under which the Akin Gump network operates worldwide, please see our Legal Notices page.